Ignite Creation Date:
2025-12-24 @ 6:35 PM
Ignite Modification Date:
2026-04-13 @ 6:01 PM
Study NCT ID:
NCT01056757
Status:
TERMINATED
Last Update Posted:
2015-11-04
First Post:
2010-01-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Treatment With Ribavirin for Patients With Metastatic Breast Cancer
Sponsor:
Jewish General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Ribavirin-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None